What is the current Price Target for the Evoke Pharma, Inc. stock?

The average Evoke Pharma, Inc. target price is $18.00. This is 277.36% higher than the current stock price. 1 Analyst has issued a Evoke Pharma, Inc. price target 2025.

How high will the Evoke Pharma, Inc. stock rise?

No reliable answer can be given as to how high the Evoke Pharma, Inc. stock will rise. The performance of stocks, including the Evoke Pharma, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Evoke Pharma, Inc. stock today?

The performance of Evoke Pharma, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Evoke Pharma, Inc. stock fall?

The decline in Evoke Pharma, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Evoke Pharma, Inc. Forecast, price target & analysts

$4.77

1.85% today

Nasdaq, Dec 30, 10:00 pm CET

ISIN

US30049G1040

Symbol

EVOK

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Evoke Pharma, Inc. Target price 2024 - Analyst rating & recommendation

Evoke Pharma, Inc. Classifications & Recommendation:

Buy

100%

Evoke Pharma, Inc. Price Target

Target Price	$18.00
Price	$4.77
Potential	277.36% register free of charge
Number of Estimates	1

	1 Analyst has issued a Evoke Pharma, Inc. price target 2025. The average Evoke Pharma, Inc. target price is $18.00. This is 277.36% register free of charge higher than the current stock price.
	A rating was issued by 1 analysts: 1 Analysts recommend Evoke Pharma, Inc. to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Evoke Pharma, Inc. stock has an average upside potential 2025 of 277.36% register free of charge . Most analysts recommend the Evoke Pharma, Inc. stock at Purchase.

Sales and Margin forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '23	2024 Estimates
Revenue Million $	5.18	10.02
	106.37%	93.51%

1 Analyst has issued a sales forecast Evoke Pharma, Inc. 2024 . The average Evoke Pharma, Inc. sales estimate is

Unlock

. This is

Unlock

than the revenue of the last 12 months(TTM). The highest sales forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics:

2023	$5.2m	106.37%
2024	$10.0m 93.51% Unlock
2025	$20.0m 99.51% Unlock
2026	$32.0m 60.15% Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '23	2024 Estimates
EV/Sales		0.09

Based on analysts' sales estimates for 2024, the Evoke Pharma, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

Unlock

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of

Unlock

This results in the following potential growth metrics and future valuations:

Current	0.10	85.07%
2024	0.09 12.20% Unlock
2025	0.04 49.89% Unlock
2026	0.03 37.50% Unlock

Current	0.84	6.20%
2024	0.72 14.00% Unlock
2025	0.36 49.88% Unlock
2026	0.23 37.56% Unlock

Evoke Pharma, Inc....

Discover more stocks with a high price target

Valneva 268.86%

CureVac N.V. 117.96%

Moderna 81.31%

Bavarian Nordic 59.49%

Teamviewer 56.15%

RWE 47.84%

Nel ASA 47.09%

Alibaba Group Holding Ltd 43.74%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now